MEET THE TEAM
Kevin started his statistical career in 1990 with Amgen. After three years, he moved to Wellcome and stayed in the GSK family of companies for a number of years. Having held a variety of positions, including project statistician and technical support gives Kevin a broad oversight of the clinical trial process. Kevin set up PHASTAR in 2007 and is a Chartered Statistician and a former Board Member for PSI (Statisticians in the Pharmaceutical Industry). He is still actively involved in providing statistical support.
Andrew began his career in statistical programming 22 years ago and subsequently held various technical roles in contract research organizations. He has served on several boards and has worked in both the UK and the USA in leadership roles with a focus on growing businesses. Andrew is responsible for the operational delivery at PHASTAR as well the oversight of Quality Assurance, Finance, Administration, and Human Resources. He holds a Law degree from the Open University and an MBA from Newcastle University.
Josh has many years industry experience, developing and leading a number of biostatistics departments. He has extensive regulatory experience (IND, CTA, BLA, MAA, and post-licensing) in all geographies, including submission strategy and preparation; and has participated in multiple advisory committee meetings at the FDA for new therapeutics (small molecule and biologics). Josh leads our US operations from our headquarters in North Carolina and is actively involved in providing statistical support.
Pam joined the PHASTAR team after working in statistical and alliance management roles for more than 20 years in a large pharmaceutical company. Pam has extensive knowledge and experience of working within an alliance framework, from the initial vendor selection process through to establishing new partnerships, whilst effectively managing existing relationships. She has developed strong connections with a variety of analysis and reporting customers, ranging from models working with low cost offshore providers to large global organizations. Alongside this, Pam works with multiple global internal teams within the pharmaceutical industry to meet their reporting and regulatory requirements.
With more than 30 years of experience in clinical data management, Sheelagh has directed and delivered projects in all phases of clinical trials across numerous therapeutic areas and data collection platforms. Sheelagh holds a BSc in pharmacology and doctorate in pharmacokinetics from the University of Bath. She has led PHASTAR’s Data Operations group since 2016.
Prior to joining PHASTAR, Nadeem had over 26 years' experience at GSK in a variety of analytical roles supporting drug development through to commercialization. During his early career, he provided statistical consultancy to non-clinical and clinical projects across multiple therapeutic areas and phases of development. Nadeem was responsible for driving the GSK statistics and programming resourcing strategy globally, building strong partnerships with external functional service providers, while managing internal stakeholders. Nadeem joined PHASTAR in 2015 taking responsibility for account strategy and management for some of our largest clients.
Professor Jennifer Rogers
Jen joined PHASTAR as Head of Statistical Research in August 2019, following a move from the University of Oxford where she was Director of Statistical Consultancy Services and an Associate Professor in the Department of Statistics. She had previously worked as a Post-Doctoral Research Fellow in the Department of Statistics funded by the National Institute of Health Research. Formerly Vice President for External Affairs at the RSS and now a member of its COVID-19 task force, Jen directs the statistical research strategy helping the company stay at the cutting edge of new methodological advances.
Alastair is a statistician with over 25 years of experience as both a manager and with hands-on statistical analysis and reporting. With experience in managing groups delivering projects to tight timelines at small to mid-sized CROs and a keen interest in process improvement initiatives, Alastair is responsible for heading up the Operational Excellence group within PHASTAR which is charged with the identification and delivery of efficiencies and improvements.
Dr Jennifer Bradford
Jenny leads PHASTAR’s data science group, a team of experienced data scientists that are applying advanced analytical approaches, including artificial intelligence and machine learning to maximize the value of clinical trial data. Jenny’s background in data science spans over 15 years and prior to joining PHASTAR in 2019, Jenny worked for AstraZeneca and Cancer Research UK.
Michelle began her career in the pharmaceutical industry in 1998, working in both pharmaceutical companies and CROs. Initially working as a statistician, she has experience in phase II-IV clinical trials across a wide range of therapeutic areas. After a transition into resource management she now heads up the Project Management Office, overseeing the program of work across PHASTAR to ensure projects are delivered on time, on budget and of the highest quality.
LaRee has more than 24 years’ experience in clinical research, industry regulation and clinical operations, including over 16 years working as an FDA CDER statistician. Her areas of expertise include biostatistics, experimental and observational study design, as well as significant experience with FDA processes and regulations.
As Director of Biostatistics, Paul leads PHASTAR’s office in the Boston-Cambridge area. Paul brings with him over 20 years of clinical trials experience and has served as a director for more than 13 years at CROs and in medical centers and academic settings. Paul has applied statistics to medical devices and drugs for cardiology, nephrology, oral health, environmental health and oncology and has also authored and co-authored more than 65 manuscripts in peer-reviewed journals.
With a background in programming, Ryan has extensive experience working in the pharmaceutical and CRO industry and leading a clinical analytics department in both Japan and China. Ryan is responsible for delivering PHASTAR’s business strategy in Japan – business development, plans and processes for delivery of clinical trial projects, alongside staff recruitment and development. Ryan also provides oversight of clinical trial projects to ensure they are delivered to agreed timelines with optimal quality.
Ed has overall responsibility for the sales and marketing functions within PHASTAR, including the business development, marketing and the contracts and proposals groups. Ed joined PHASTAR in 2017 after working in a number of significant commercial roles across the pharmaceutical industry. As Director of Sales and Marketing, Ed is responsible for sharing PHASTAR’s global technical expertise with trial sponsors.
Kirsty began her career in recruitment 10 years ago and is responsible for leading an expert team of recruiters to find the best talent for PHASTAR. With a focus on quality, she has supported PHASTAR's global growth plans with strategic hiring and developing and delivering a comprehensive graduate program.
Barbara began her career in programming over 20 years ago and held various programming and leadership positions in the pharmaceutical industry prior to joining PHASTAR in 2017. As Head of Strategic Programming Support, Barbara provides technical and strategic programming support within the company, including technical programming input to RFIs and RFPs for prospective and existing clients, providing technical programming advice to technical support for internal reporting teams and advising on programming best practices for the reporting of clinical trial and regulatory submissions.
James started his programming career at a global CRO before moving to Pharma, spending the majority of his career based in Basel, Switzerland. James' 23 years’ experience includes early and late-phase clinical trials, HTA and e-Submissions. James leads PHASTAR’s global programming group from our Sheffield office, focusing on providing the highest quality of programming expertise to PHASTAR’s clients.
Gary began work as a statistician in 1992 and spent a large part of his career at Boehringer Ingelheim, working as Country Head of Statistics in the UK and more recently as Global Head of Statistical Programming. Gary is active in industry conference and event organization and was involved in organizing the PSI conferences and one-day events as well as co-chair for the PHUSE conference. Gary is currently an Account Manager at PHASTAR and continues to look for ways to innovate, which has been a passion of his throughout his career.
Michael’s career started as a statistician designing and analyzing investigator led clinical trials with the University of Newcastle, Australia. In 2012 Michael joined PHASTAR in London where he has worked across all aspects and stages of pharmaceutical and biotech industry clinical trials, from hands on clinical trial analysis and reporting to working with multi-disciplinary study teams to design full clinical development plans. Michael now leads our highly skilled biometrics team in Australia to support our customers throughout the region.